BiotechTube
Home/Pipeline/Novel RNA Therapeutic Discovery

Novel RNA Therapeutic Discovery

Not Specified

Pre-clinicalActive

Key Facts

Indication
Not Specified
Phase
Pre-clinical
Status
Active
Company
Genomic Expression

About Genomic Expression

Genomic Expression is a Copenhagen-based biotech leveraging its OneRNA® platform to transform cancer care through comprehensive RNA analysis. The company's initial commercial application is in breast and ovarian cancer, where its test identifies multiple treatment options, including approved drug repurposing, for individual patients. Led by an experienced team, the company is transitioning from an angel-funded, grant-supported startup to raising a Series A to scale its diagnostic offerings and expand its pipeline into novel RNA therapeutic development. Its vision is to make AI-driven, RNA-based precision medicine a standard part of clinical care.

View full company profile

Therapeutic Areas

Oncology

Other Not Specified Drugs

DrugCompanyPhase
FL116Forlong BiotechnologyNot specified
FL117Forlong BiotechnologyNot specified
FL118Forlong BiotechnologyNot specified
FL301Forlong BiotechnologyNot specified
JSKN016AlphaMab OncologyPhase 1
JSKN033AlphaMab OncologyPhase 1
JSKN022AlphaMab OncologyPhase 1
JSKN027AlphaMab OncologyPhase 1
KN019AlphaMab OncologyPhase 1
New TCM FormulationsChina SXT PharmaceuticalsResearch / Pre-clinical
Long-acting LeronlimabCytoDynPreclinical
SR2162SIMR (Australia) BiotechIND Approved